Rapid Dose Therapeutics Corp. (“ RDT” ), ( CSE: DOSE) , a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, announces that, further to its press release dated June 16, 2022 (the “Default Announcement”), at the request of the Company, the Ontario Securities Commission (the “OSC”) has issued a management cease trade order (the “MCTO”) pursuant to National Policy 12-203.
June 30, 2022
· 4 min read